NEW evidence suggests cardiovascular risk prediction can be significantly improved by combining clinical biomarkers, metabolomics and genetics, potentially allowing clinicians to identify high risk individuals earlier and prevent more…
NEW evidence suggests cardiovascular risk prediction can be significantly improved by combining clinical biomarkers, metabolomics and genetics, potentially allowing clinicians to identify high risk individuals earlier and prevent more…